A study to investigate the clinical outcome and quality of life in Chinese post-operative CRSwNP patients

Trial Identifier: D5242R00005
Sponsor: AstraZeneca
Start Date: March 2026
Primary Completion Date: August 2027
Study Completion Date: August 2027
Condition: Nose and Sinus Disorder

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Changchun, China, 130033
China Chengdu, China, 610078
China Guangzhou, China, 514700
China Guangzhou, China, 510062
China Haikou, China, 570311
China Nanning, China, 530021
China Shanghai, China, 200031
China Urumqi, China, 830054
China Wuhan, China, 430000
China Xiamen, China, 361003